Microbial factors in inflammatory bowel disease (Q33337420)

25 July 2017

1 reference

title

Microbial factors in inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

25 July 2017

main subject

0 references

inflammation

0 references

author name string

Richard J Farrell

series ordinal

1

1 reference

25 July 2017

J Thomas LaMont

series ordinal

2

1 reference

25 July 2017

publication date

1 March 2002

1 reference

Gastroenterology Clinics of North America

25 July 2017

published in

1 reference

25 July 2017

volume

31

1 reference

25 July 2017

issue

1

1 reference

25 July 2017

page(s)

41-62

1 reference

Controlled trial of antimycobacterial therapy in Crohn's disease. Clofazimine versus placebo

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Absence of measles-virus genome in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4( ) TH1-like responses

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Spontaneous chronic colitis in TCR alpha-mutant mice; an experimental model of human ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Microbial causation of the chronic idiopathic inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

The neglected organ: bacterial flora has a crucial immunostimulatory role

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

A Study of Liver Disorder in Ulcerative Colitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Clostridium difficile, sulphasalazine, and ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative?

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified Mycobacterium species isolated from patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Crohn's disease and the mycobacterioses: a review and comparison of two disease entities

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

CD4 T Cells Reactive to Enteric Bacterial Antigens in Spontaneously Colitic C3H/HeJBir Mice: Increased T Helper Cell Type 1 Response and Ability to Transfer Disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Short chain fatty acids in the human colon

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Helicobacter hepaticus does not induce or potentiate colitis in interleukin-10-deficient mice

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Perinatal measles infection and subsequent Crohn's disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Does the failure to acquire helminthic parasites predispose to Crohn's disease?

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Antibiotics are not effective therapy for Crohn's disease (time to remove the rose-coloured glasses)

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Inflammatory bowel disease: etiology and pathogenesis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Hepatic Helicobacter species identified in bile and gallbladder tissue from chileans with chronic cholecystitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Comparative study of Mycobacterium paratuberculosis strains isolated from Crohn's disease and Johne's disease using restriction fragment length polymorphism and arbitrarily primed polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Combination Ciprofloxacin and Metronidazole for Active Crohn’s Disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Clostridium difficile and inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Role of the faecal stream in the maintenance of Crohn's colitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Recurrence of Crohn's disease in end ileostomies

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Mucosal cell-mediated immunity to mycobacterial, enterobacterial and other microbial antigens in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Absence of measles virus in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

The role of cytokines in the immune response to tuberculosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Cytomegalovirus colitis in the immunocompetent host: an overview

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Increased risk of bacterial endocarditis in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Open label trial of oral clarithromycin in active Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease?

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Is small intestinal permeability really increased in relatives of patients with Crohn's disease?

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Tissue interleukin 1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats.

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Factors inducing relapse in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Seasonal variations in the onset of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Stimulation of transforming growth factor β1 by enteric bacteria in the pathogenesis of rat intestinal fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Antibiotics are effective therapy for Crohn's disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Hydrogen sulphide: a bacterial toxin in ulcerative colitis?

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Ulcerative post-dysenteric colitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Colonic mucus and mucosal glycoproteins: the key to colitis and cancer?

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Measles virus and Crohn's disease: a critical appraisal of the current literature

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Inhibition of delayed hypersensitivity by metronidazole and misonidazole

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Occurrence of Clostridium difficile toxin in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Mycobacterium paratuberculosis DNA not detected in Crohn's disease tissue by fluorescent polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Are short–chain fatty acid enemas effective for left–sided ulcerative colitis?

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Therapy of inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Postoperative recurrence of Crohn's disease: The enemy is within the fecal stream

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Enteric Microflora in IBD: Pathogens or Commensals?

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Frequency of pathogenic and enteroadherent Escherichia coli in patients with inflammatory bowel disease and controls

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Identification of widespread Helicobacter hepaticus infection in feces in commercial mouse colonies by culture and PCR assay

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

IMMUNOLOGY: Therapeutic Manipulation of Gut Flora

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Double blind, placebo controlled trial of metronidazole in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Controlled trial of antituberculous chemotherapy in Crohn's disease: a five year follow up study

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Long-term treatment of ulcerative colitis with ciprofloxacin: a prospective, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

The resident faecal flora is determined by genetic characteristics of the host. Implications for Crohn's disease?

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Granulomatous vasculitis in crohn's disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Evidence of persistent measles virus infection in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Absence of Escherichia coli, Listeria monocytogenes, and Klebsiella pneumoniae antigens within inflammatory bowel disease tissues

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Antibodies against Mycobacterium paratuberculosis in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Arthritis associated with intestinal-bypass procedure for morbid obesity. Complement activation and characterization of circulating cryoproteins

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Bacteroides fragilis enterotoxin modulates epithelial permeability and bacterial internalization by HT-29 enterocytes

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

Immunomodulatory action of levofloxacin on cytokine production by human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016/S0889-8553(01)50004-8

7 January 2021

10.1016/S0889-8553(01)00004-8

Identifiers

DOI

1 reference

25 July 2017

1 reference